Macquarie Group
ELAT

Macquarie Group’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Macquarie Group’s Portfolio ELAT Stock Details ELAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-77,293
Closed -$1.51M – 1815
2022
Q4 		$1.51M Hold
77,293
– – ﹤0.01% 1293
2022
Q3 		$1.6M Hold
77,293
– – ﹤0.01% 1300
2022
Q2 		$2.47M Hold
77,293
– – ﹤0.01% 1229
2022
Q1 		$3.19K Buy
77,293
+4,550
+6% +$191K ﹤0.01% 1237
2021
Q4 		$3.25M Buy
+72,743
New +$3.5M ﹤0.01% 1234
2021
Q3 		– Hold
0
– – – 1032
2021
Q2 		– Hold
0
– – – 1037
2020
Q2 		– Hold
0
– – – 938

Macquarie Group's ELAT Position: Q1 2023 in Review

Macquarie Group sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 77,293 shares — an estimated $1.51M sold.

Macquarie Group first reported a position in ELAT in Q4 2021 and held it in 5 quarters. The position peaked at $3.25M in Q4 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

  • Macquarie Group reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
  • Macquarie Group sold 77,293 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $1.51M.
  • Macquarie Group first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q4 2021 and held it in 5 quarters.
  • Macquarie Group's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $3.25M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Macquarie Group's 13F filing for Q1 2023, filed 15 May 2023.